Adenomyoepithelioma - 37 Studies Found
Recruiting |
: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium :
|
Recruiting |
: A Study of ENMD-2076 in Ovarian Clear Cell Cancers : Ovarian Clear Cell Carcinoma : 2013-07-11 : Drug: ENMD-2076 |
Recruiting |
: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma :
: 2013-03-19 : Drug: Sunitinib 37.5mg everyday from D1-D28 Other Na |
Recruiting |
: MEDI4736 Combinations in Metastatic Renal Cell Carcinoma :
: 2016-02-22 : |
Completed |
: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer :
|
Completed |
: AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib : Advanced Renal Cell Carcinoma : 2007-04-26 :
|
Withdrawn |
: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) :
|
Completed |
: Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney : Kidney Cancer : 2009-02-26 :
|
Active, not recruiting |
: Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer :
|